Ampelopsin E reduces the invasiveness of the triple negative breast cancer cell line, MDA-MB-231

Breast cancer is the most common and the second leading cause of cancer-related deaths in women. It has two distinctive hallmarks: rapid abnormal growth and the ability to invade and metastasize. During metastasis, cancer cells are thought to form actin-rich protrusions, called invadopodia, which de...

Full description

Bibliographic Details
Main Authors: Tieng, Francis Yew Fu, Saiful Yazan, Latifah, Md Hashim, Nur Fariesha, Khaza'ai, Huzwah, Ahmat, Norizan, Gopalsamy, Banulata, Wibowo, Agustono
Format: Article
Language:English
Published: MDPI 2019
Online Access:http://psasir.upm.edu.my/id/eprint/38300/1/38300.pdf
_version_ 1796973318833700864
author Tieng, Francis Yew Fu
Saiful Yazan, Latifah
Md Hashim, Nur Fariesha
Khaza'ai, Huzwah
Ahmat, Norizan
Gopalsamy, Banulata
Wibowo, Agustono
author_facet Tieng, Francis Yew Fu
Saiful Yazan, Latifah
Md Hashim, Nur Fariesha
Khaza'ai, Huzwah
Ahmat, Norizan
Gopalsamy, Banulata
Wibowo, Agustono
author_sort Tieng, Francis Yew Fu
collection UPM
description Breast cancer is the most common and the second leading cause of cancer-related deaths in women. It has two distinctive hallmarks: rapid abnormal growth and the ability to invade and metastasize. During metastasis, cancer cells are thought to form actin-rich protrusions, called invadopodia, which degrade the extracellular matrix. Current breast cancer treatments, particularly chemotherapy, comes with adverse effects like immunosuppression, resistance development and secondary tumour formation. Hence, naturally-occurring molecules claimed to be less toxic are being studied as new drug candidates. Ampelopsin E, a natural oligostilbene extracted from Dryobalanops species, has exhibited various pharmacological properties, including anticancer and anti-inflammatory activities. However, there is yet no scientific evidence of the effects of ampelopsin E towards metastasis. Scratch assay, transwell migration and invasion assays, invadopodia and gelatin degradation assays, and ELISA were used to determine the effects of ampelopsin E towards the invasiveness of MDA-MB-231 cells. Strikingly in this study, ampelopsin E was able to halt migration, transmigration and invasion in MDA-MB-231 cells by reducing formation of invadopodia and its degradation capability through significant reduction (p < 0.05) in expression levels of PDGF, MMP2, MMP9 and MMP14. In conclusion, ampelopsin E reduced the invasiveness of MDA-MB-231 cells and was proven to be a potential alternative in treating TNBC.
first_indexed 2024-03-06T08:40:53Z
format Article
id upm.eprints-38300
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T08:40:53Z
publishDate 2019
publisher MDPI
record_format dspace
spelling upm.eprints-383002020-05-04T16:14:23Z http://psasir.upm.edu.my/id/eprint/38300/ Ampelopsin E reduces the invasiveness of the triple negative breast cancer cell line, MDA-MB-231 Tieng, Francis Yew Fu Saiful Yazan, Latifah Md Hashim, Nur Fariesha Khaza'ai, Huzwah Ahmat, Norizan Gopalsamy, Banulata Wibowo, Agustono Breast cancer is the most common and the second leading cause of cancer-related deaths in women. It has two distinctive hallmarks: rapid abnormal growth and the ability to invade and metastasize. During metastasis, cancer cells are thought to form actin-rich protrusions, called invadopodia, which degrade the extracellular matrix. Current breast cancer treatments, particularly chemotherapy, comes with adverse effects like immunosuppression, resistance development and secondary tumour formation. Hence, naturally-occurring molecules claimed to be less toxic are being studied as new drug candidates. Ampelopsin E, a natural oligostilbene extracted from Dryobalanops species, has exhibited various pharmacological properties, including anticancer and anti-inflammatory activities. However, there is yet no scientific evidence of the effects of ampelopsin E towards metastasis. Scratch assay, transwell migration and invasion assays, invadopodia and gelatin degradation assays, and ELISA were used to determine the effects of ampelopsin E towards the invasiveness of MDA-MB-231 cells. Strikingly in this study, ampelopsin E was able to halt migration, transmigration and invasion in MDA-MB-231 cells by reducing formation of invadopodia and its degradation capability through significant reduction (p < 0.05) in expression levels of PDGF, MMP2, MMP9 and MMP14. In conclusion, ampelopsin E reduced the invasiveness of MDA-MB-231 cells and was proven to be a potential alternative in treating TNBC. MDPI 2019 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/38300/1/38300.pdf Tieng, Francis Yew Fu and Saiful Yazan, Latifah and Md Hashim, Nur Fariesha and Khaza'ai, Huzwah and Ahmat, Norizan and Gopalsamy, Banulata and Wibowo, Agustono (2019) Ampelopsin E reduces the invasiveness of the triple negative breast cancer cell line, MDA-MB-231. Molecules, 24 (14). art. no. 2619. pp. 1-25. ISSN 1420-3049 https://www.mdpi.com/1420-3049/24/14/2619 10.3390/molecules24142619
spellingShingle Tieng, Francis Yew Fu
Saiful Yazan, Latifah
Md Hashim, Nur Fariesha
Khaza'ai, Huzwah
Ahmat, Norizan
Gopalsamy, Banulata
Wibowo, Agustono
Ampelopsin E reduces the invasiveness of the triple negative breast cancer cell line, MDA-MB-231
title Ampelopsin E reduces the invasiveness of the triple negative breast cancer cell line, MDA-MB-231
title_full Ampelopsin E reduces the invasiveness of the triple negative breast cancer cell line, MDA-MB-231
title_fullStr Ampelopsin E reduces the invasiveness of the triple negative breast cancer cell line, MDA-MB-231
title_full_unstemmed Ampelopsin E reduces the invasiveness of the triple negative breast cancer cell line, MDA-MB-231
title_short Ampelopsin E reduces the invasiveness of the triple negative breast cancer cell line, MDA-MB-231
title_sort ampelopsin e reduces the invasiveness of the triple negative breast cancer cell line mda mb 231
url http://psasir.upm.edu.my/id/eprint/38300/1/38300.pdf
work_keys_str_mv AT tiengfrancisyewfu ampelopsinereducestheinvasivenessofthetriplenegativebreastcancercelllinemdamb231
AT saifulyazanlatifah ampelopsinereducestheinvasivenessofthetriplenegativebreastcancercelllinemdamb231
AT mdhashimnurfariesha ampelopsinereducestheinvasivenessofthetriplenegativebreastcancercelllinemdamb231
AT khazaaihuzwah ampelopsinereducestheinvasivenessofthetriplenegativebreastcancercelllinemdamb231
AT ahmatnorizan ampelopsinereducestheinvasivenessofthetriplenegativebreastcancercelllinemdamb231
AT gopalsamybanulata ampelopsinereducestheinvasivenessofthetriplenegativebreastcancercelllinemdamb231
AT wibowoagustono ampelopsinereducestheinvasivenessofthetriplenegativebreastcancercelllinemdamb231